Aptamer‐Crosslinked Microbubbles: Smart Contrast Agents for Thrombin‐Activated Ultrasound Imaging
- 3 September 2012
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 24 (45) , 6010-6016
Abstract
Thrombosis, or malignant blood clotting, is associated with numerous cardiovascular diseases and cancers. A microbubble contrast agent is presented that produces ultrasound harmonic signal only when exposed to elevated thrombin levels. Initially silent microbubbles are activated in the presence of both thrombin‐spiked and freshly clotting blood in three minutes with detection limits of 20 nM thrombin and 2 aM microbubbles.Keywords
This publication has 21 references indexed in Scilit:
- Sonography of thrombosis of the deep veins of the extremities: Clinical perspectives and imaging reviewJournal of Clinical Ultrasound, 2011
- DNA‐Coated Microbubbles with Biochemically Tunable Ultrasound Contrast ActivityAdvanced Materials, 2011
- Facile one-pot synthesis of polymer–phospholipid composite microbubbles with enhanced drug loading capacity for ultrasound-triggered therapySoft Matter, 2011
- Protease‐Triggered Unveiling of Bioactive NanoparticlesSmall, 2008
- Deformable gas-filled microbubbles targeted to P-selectinJournal of Controlled Release, 2006
- Structure-Switching Signaling AptamersJournal of the American Chemical Society, 2003
- Oscillations of polymeric microbubbles: Effect of the encapsulating shellThe Journal of the Acoustical Society of America, 2000
- Perfluorocarbon-enhanced sonography: value in detecting acute venous thrombosis in rabbits.American Journal of Roentgenology, 1994
- Selection of single-stranded DNA molecules that bind and inhibit human thrombinNature, 1992
- Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengthsCell Calcium, 1985